CD44 and cancer: Various markers, including CD44, CD133, ALDH1, and EpCAM, have been widely used to identify and isolate CSCs from different cancer types.445 However, these markers are not universally expressed across all CSCs; they are often shared with NSCs, raising concerns regarding specificity and potential off-target effects.